NEXTBio Capital Management LP
AUSTIN, TX · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$234.4M2026 Q3
Positions25
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.67.6%
NEXTBio Capital Management LP reported 25 positions worth $234.4M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: PTGX (13.2%).
10 / 25 positions shown
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | PTGX | $30.9M | 13.19% | 219,333 | — | — | -11.4% | |
| ▸ 2 | STTK | $25.4M | 10.85% | 3,727,348 | — | — | -14.1% | |
| ▸ 3 | CMPS | $22.1M | 9.43% | 1,775,759 | — | — | -33.5% | |
| ▸ 4 | RYTM | $12.5M | 5.35% | 131,758 | — | — | +12.9% | |
| ▸ 5 | VOR | $11.8M | 5.05% | 620,931 | — | — | -0.6% | |
| ▸ 6 | PHVS | $11.8M | 5.04% | 372,552 | — | — | +2.3% | |
| ▸ 7 | XENE | $11.5M | 4.92% | 310,225 | — | — | +5.6% | |
| ▸ 8 | ZBIO | $11.5M | 4.91% | 426,736 | — | — | — | |
| ▸ 9 | PVLA | $11.1M | 4.73% | 80,409 | — | — | +4.8% | |
| ▸ 10 | GPCR | $9.8M | 4.17% | 312,496 | — | — | -36.0% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does NEXTBio Capital Management LP hold as of Q3 2026?
NEXTBio Capital Management LP reported 25 positions worth $234.4M in its Q3 2026 13F filing. Largest positions: PTGX (13.2%), STTK (10.8%), CMPS (9.4%), RYTM (5.4%) and VOR (5.1%).
What did NEXTBio Capital Management LP buy in Q3 2026?
No previous quarter is available yet; the comparison appears with the next filing.
What did NEXTBio Capital Management LP sell in Q3 2026?
No previous quarter is available yet.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.